![](https://privsource-prod.s3.amazonaws.com/gpqrbdan43tm77wabs6y9a6tvkl3?response-content-disposition=inline%3B%20filename%3D%22qhp.png%22%3B%20filename%2A%3DUTF-8%27%27qhp.png&response-content-type=image%2Fpng&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA6NYHEBQEVFIPN3SJ%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T094441Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=acca37ec0c028e95e8959de89864eec83ece1da80499b5db49dd00d832a37afe)
QHP Capital Invests in AutoCruitment
10.27.2022
Since 2013, AutoCruitment has helped pharma companies, biotechs, and clinical research organizations ("CROs") in identifying, screening and recruiting patients to participate in clinical research across a wide range of therapeutic areas. By streamlining the patient recruitment process with digital and automated screening technology, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →